The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains

Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis

(2010) Won Hyeok Choe et al.   LIVER INTERNATIONAL

Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir

(2009) Wilhelmus F. Leemans et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Treatment of chronic hepatitis B and the implications of viral resistance to therapy

(2008) Stefan Mauss et al.   Expert Review of Anti-Infective Therapy

Role of tenofovir in the treatment of chronic HBV infection

(2008) Florian van Bömmel et al.   Future Virology

Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance

(2008) Carl J. Baldick et al.   HEPATOLOGY

Hepatitis B goes globe: Telbivudine as a new treatment option

(2008) Frank Tacke et al.   HEPATOLOGY

Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations

(2008) Jessica Tan et al.   JOURNAL OF HEPATOLOGY

Symptomatic Hepatitis B Virus (HBV) Reactivation despite Reduced Viral Fitness Is Associated with HBV Test and Immune Escape Mutations in an HIV‐Coinfected Patient

(2008) Cornelia Henke‐Gendo et al.   JOURNAL OF INFECTIOUS DISEASES